You are here: Startpage > Pharma Research > Proof of Concept

Proof of Concept / Efficacy studies

In addition to studies for determining local tolerability, proDERM Pharma also offers a series of methods for testing the efficacy of dermatological, allergological, ophthalmological and dental medicines.

Proof of concept studies are conducted on symptomatic test subjects and represent a huge challenge when it comes to recruitment. proDERM Pharma, however, already has a pool of appropriately prescreened studies. Thus, we can reduce time of recruitment and increase the compliance.

In addition to standard Proof of Concept studies with patients we also offer numerous models to generate symptoms enabling us to investigate anti-inflammatory efficacy, local anaesthetic effects or reduction of pruritus in healthy subjects in a timely manner.

News and Events

Non-Invasive Measurement of Age-Related Skin Damage

Presentation by Stephan Bielfeldt at the Anti-Ageing Skin Care Conference


Decision of British Advertising Standards Authority (ASA) confirms:

proDERM Quality Seal provides solid substantiation of "dermatologically approved" claims


  • Psoriasis Plaque Test
  • Vasoconstriction test / Blanching
  • Suction Blister Model
  • UV Erythema
  • Lesion count
  • Dermatological assessment
  • Acne
  • Atopic Dermatitis
  • Psoriasis
  • Type I & IV Allergy
  • Rosacea
  • Dry Eyes
  • Inflammation / wound healing
  • Hyperhidrosis
  • Herpes simplex
  • Tewameter
  • IR Thermography
  • Chromametry
  • UVA/UBA Irradiation
  • Corneometry
  • Confocal Microscopy
  • Laser Doppler
  • Ultrasound
  • FLPI
  • USR-CliP: Unit for standardized and
    reproducible clinical photography
  • Raman Spectroscopy

...a vasoconstriction test is usually conducted with more than 100 subjects and that proDERM provides complete recruitment within 6 weeks!